Renal Cell Carcinoma: Natural History and Chemotherapeutic Experience (Q48443836)

11 February 2018

http://europepmc.org/abstract/MED/1142517

title

Renal Cell Carcinoma: Natural History and Chemotherapeutic Experience (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

13 October 2023

1 reference

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1142517

13 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

13 October 2023

author name string

J. J. Lokich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1142517

13 October 2023

J. H. Harrison

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1142517

13 October 2023

language of work or name

English

0 references

publication date

1 September 1975

1 reference

11 February 2018

http://europepmc.org/abstract/MED/1142517

full work available at URL

https://api.elsevier.com/content/article/PII:S0022534717670320?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

https://api.elsevier.com/content/article/PII:S0022534717670320?httpAccept=text/plain

13 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

http://www.jurology.com/doi/pdf/10.1016/S0022-5347%2817%2967032-0

13 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

13 October 2023

1 reference

11 February 2018

http://europepmc.org/abstract/MED/1142517

volume

114

1 reference

11 February 2018

http://europepmc.org/abstract/MED/1142517

issue

3

1 reference

11 February 2018

http://europepmc.org/abstract/MED/1142517

page(s)

371-374

1 reference

11 February 2018

http://europepmc.org/abstract/MED/1142517

cites work

Prognosis in renal carcinoma

2

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Renal cell carcinoma.Natural history and results of treatment

13 October 2023

4

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

A case of spontaneous regression of pulmonary metastases arising from hypernephroma following nephrectomy

13 October 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Regression of metastatic renal cell carcinoma following nephrectomy

13 October 2023

7

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

The systemic effects of malignant renal tumours

13 October 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Reversible hepatic dysfunction associated with hypernephroma

13 October 2023

9

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Diagnosis and management of renal cell carcinomaA clinical and pathologic study of 309 cases

13 October 2023

11

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

New growths of the kidney and ureter

13 October 2023

12

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Autoantibodies to Human Renal Cell Carcinoma

13 October 2023

13

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Treatment of Metastatic Hypernephroma

13 October 2023

14

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

The current status of chemotherapy for advanced renal carcinoma.

13 October 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Hormonal therapy in advanced renal cell carcinoma

13 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Hormonal Treatment of Metastases of Renal Carcinoma

13 October 2023

17

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Medroxyprogesterone Acetate (Provera) in the Treatment of Metastatic Renal Cancer

13 October 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

The Value of Radiotherapy in the Treatment of Hypernephroma-a Clinical Trial

13 October 2023

19

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

Adjuvant Therapy for Adenocarcinoma of the Kidney: Present Position and Prospects1

13 October 2023

20

1 reference

https://api.crossref.org/works/10.1016/S0022-5347(17)67032-0

13 October 2023

Identifiers

1 reference

11 February 2018

http://europepmc.org/abstract/MED/1142517

1 reference

11 February 2018